F. Ricciardolo (Orbassano (Torino), Italy), C. Page (London, United Kingdom), B. Oliver (Sydney, Australia), M. Contoli (Ferrara , Italy)
Efficacy of Levodropropizine: 2 metanalysis in pediatric and adult population
A. Zanasi, F. De Blasio, L. Lanata, F. Saibene, G. Fontana (Bologna, Naples, Milan, Florence, Italy)
|   |
An open-label pilot study of memantine, an N-methyl-D-aspartate receptor antagonist in chronic cough
R. Abdulqwai, R. Dockry, H. Kimberley, S. Sen, E. Hilton, J. Smith (Manchester, United Kingdom)
| |
Integrated safety across six clinical trials of alpha-1 augmentation therapy
R. Sandhaus, K. R. Chapman, J. Burdon, E. Piitulainen, N. Seersholm, J. Stocks, J. Edelman, M. Bexon, L. Huang, N. G. McElvaney (Denver, Tyler, King of Prussia, United States Of America; Toronto, Canada; Melbourne, Australia; Malmo, Sweden; Hellerup, Denmark; Bern, Switzerland; Dublin, Ireland)
| |
Abediterol has higher bronchodilatory potency than other long-acting beta2-receptor agonists in a guinea pig model
J. De Alba, R. Otal, J. A. Fernández-Blanco, M. Aparici, C. Puig, A. Gavaldà, M. Miralpeix (Barcelona, Spain)
| |
Abediterol has higher beta2-receptor affinity and in vitro bronchodilatory potency than other long-acting beta2-agonists, with good selectivity
M. Miralpeix, M. Aparici, C. Carcasona, I. Ramos, C. Puig, D. Vilella, A. Gavaldà (Barcelona, Spain)
| |
Effects of inhaled salmeterol/fluticasone on lung function in patients with bronchiectasis
P. Thongmak, N. Piyavisetpat, S. Wongtim, K. Kawkitinarong (Bangkok, Thailand)
| |
Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle
M. Cazzola, L. Calzetta, C. P. Page, F. Facciolo, A. Gavaldà, M. G. Matera (Rome, Naples, Italy; London, United Kingdom; Barcelona, Spain)
| |
Plume temperature and force of fluticasone propionate/formoterol pMDI compared with fluticasone propionate/salmeterol pMDI
B. Johal, J. Tuohy, J. Marshall (Cambridge, United Kingdom; Carrick-on-Shannon, Ireland)
| |
Are ultrafine particle inhalers, better for patients with small airway involvement?
B. Gemicioglu, G. Pasaoglu Karakis, B. Duman, M. Uygun (Istanbul, Turkey)
| |
Comparison of budesonide and fluticasone propionate on COPD macrophage phagocytosis and killing of bacteria
K. Belchamber, A. Turner, R. Holloway, P. Barnes, L. Donnelly (London, United Kingdom)
| |
Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium
I. Heijink, M. Jonker, D. Postma, M. Van den Berge (Groningen, Netherlands)
| |
Comparison of three modalities of corticosteroids administration in chronic rhinosinusitis
G. Reychler, C. Colbrant, C. Huart, S. Le Guellec, L. Vecellio, P. Rombaux (Brussels, Belgium; Tours, France)
| |
AZD5069: Pharmacological profile of a CXCR2 antagonist in development for the treatment of respiratory disorders
C. Kärrman Mårdh, D. Nicholls, I. Dainty, C. Phillips, F. McIntosh (Mölndal, Sweden; Alderley Park, Charnwood, United Kingdom)
| |
Effect of the CYP3A4 inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of AZD5069, an oral CXCR2 antagonist
M. Cullberg, H. Wray, B. Larsson (Mölndal, Sweden)
| |
Investigation of the feasibility of manufacturing a spray-dried formulation of the synthetic peptide, AP301
W. Shabbir, S. Jenn, S. Tzotzos, B. Fischer, H. Pietschmann, H. Fischer, R. Lucas, R. Lemmens-Gruber (Vienna, Austria; Georgia, United States Of America)
| |
Azithromycin augments rhinovirus-induced expression of IFNbeta and IFNλ1 in asthmatic bronchial epithelial cells by up-regulating RIG-I like receptors
M. Menzel, H. Akbarshahi, L. Bjermer, L. Uller (Lund, Sweden)
| |
Plant proteinase from bauhinia bauhinioides kallikrein inhibitor (BbKI) attenuates inflammation and remodelling induced by elastase in mice
E. A. Leick, B. T. Martins Oliveira, L. V. Oliva, R. Almeida-Reis, O. A. Theodoro, M. L. V. Oliva, I. F. L. C. Tibério (São Paulo, Sao Paulo, Brazil)
| |
COPD airway epithelium secretion attracts and activates neutrophils
L. Knabe, A. Petit, N. Molinari, A. S. Gamez, I. Vachier, A. Bourdin (Montpellier, France)
| |
C-reactive protein at discharge, diabetes mellitus and ≥1 prior hospitalization predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease
E. Crisafulli, A. Huerta, R. Méndez, M. Guerrero, R. Martinez, N. Soler, S. Sethi, R. Menéndez, A. Torres (Mantova, Italy; Barcelona, Valencia, Spain; Buffalo, United States Of America)
| |
Supplementation of diabetic rats with leucine, zinc, and chromium: Effects on lung and bronchoalveolar lavage fluid oxidative stress
H. Sadri, S. Kolahian, R. Jafari Joozani, M. Mirani (Tabriz, Islamic Republic Of Iran; Bonn, Germany)
| |